Unveiling the hidden link: elevated platelets and T cell subsets in 5% of moderate COVID-19 patients 48 days post-onset
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1498491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Hui An und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhe…. Hauptthemen laut MEDLINE: COVID-19, Blood Platelets, T-Lymphocyte Subsets, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Platelets are hyperactived during acute COVID-19, promoting clotting and modulating immune-cell responses. Immune thrombocytopenia in adults can manifest as an uncommon complication resulting from various viral infections or as a rare adverse event associated with vaccination. However, their role in convalescent COVID-19 patients remains underexplored. This study examines platelet dynamics early in the pandemic, 48 days post-symptom onset, in unvaccinated patients.
Methods
This longitudinal study included 298 unvaccinated COVID-19 patients (17 mild, 281 moderate) from multiple centers. Clinical evaluations and peripheral lymphocyte subset analyses via flow cytometry were conducted upon admission and on day 48 post-symptom onset (DPSO 48).
Results
At DPSO 48, 5.3% of moderate COVID-19 patients exhibited high platelet counts (>300×10 9 /L), associated with elevated total T-cells (26.4%), CD4 T-cells (24.4%), CD8 T-cells (36.9%), and Tregs (33.9%) compared to patients with normal platelet counts. However, the CD4/CD8 T-cell ratio and T-cell subset frequencies remained unaffected, indicating ongoing T-cell homeostasis restoration. Additionally, a significant positive correlation (r=0.636, p=0.03) was found between platelet counts and B cells in patients with elevated platelet counts.
Discussion
Platelets may play a pivotal role in immune regulation during the recovery phase of COVID-19. Targeting platelets and their secreted mediators could improve immune balance in patients with immune disorders, highlighting a potential therapeutic approach for enhancing recovery in post-COVID-19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- School of Basic Medical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
An, H., Li, T., Yang, L., Zhang, X., Hu, H., Zhang, C., Wang, Y., Jin, S., & Li, M. (2024). Unveiling the hidden link: elevated platelets and T cell subsets in 5% of moderate COVID-19 patients 48 days post-onset. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1498491
Vancouver
An H, Li T, Yang L, Zhang X, Hu H, Zhang C, et al. Unveiling the hidden link: elevated platelets and T cell subsets in 5% of moderate COVID-19 patients 48 days post-onset. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1498491
BibTeX
@article{An2024,
author = {An, Hui and Li, Ting and Yang, Lanting and Zhang, Xinyue and Hu, Hao and Zhang, Chen and Wang, Yongyu and Jin, Shengwei and Li, Ming},
title = {Unveiling the hidden link: elevated platelets and T cell subsets in 5% of moderate COVID-19 patients 48 days post-onset},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1498491}
}
EUVIMED